JDS CO. Limited Pharmaceutical Import Profile — Myanmar (DGFT 2022–2026)

Name: JDS CO. Limited Pharmaceutical Import Records from India — 3 Products, $757.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

JDS CO. Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $757.7K Trade | TransData Nexus

JDS CO. Limited

Pharmaceutical Importer · Myanmar · Immunosuppressants Focus · $757.7K Total Trade · DGFT Verified

JDS CO. Limited is a pharmaceutical importer based in Myanmar with a total trade value of $757.7K across 3 products in 3 therapeutic categories. Based on 18 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. JDS CO. Limited sources from 5 verified Indian suppliers, with Cipla Limited accounting for 44.1% of imports.

JDS CO. Limited — Import Portfolio & Supplier Network

JDS CO. Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to JDS CO. Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$251.5K	11	44.1%
Sun Pharmaceutical Industries Limited	$130.6K	8	22.9%
Torrent Pharmaceuticals Limited	$100.0K

What Formulations Does JDS CO. Limited Import?

Formulation	Value	Ships
Others : lefra 20 tablet (leflunomide20mg) - Pack size 1x5x10	$100.0K	2
Tenvir (tenofovir disoproxil fumarate tablets 300MG) (1 x 30's x 8208 Pack = 246240 nos)	$50.0K	1
Seroflo 250 inhaler(cfc free)(10739 Pack)(1x120md) (salmeterol xinafoate 25mcg +fluticasone propionate 250 MCG)with	$50.0K	1
Tenvir (tenofovir disoproxil fumarate tablets 300MG)(1x30'sx13008 Pack=390240 nos)	$50.0K	1
Asthalin inhaler (cfc free) (salbutamol sulphate 100mcg) (23520 Pack )(1x 200 md/packs)	$49.3K	1
Tevir TAB 300MG 30btl mymr Each film coat.TAB.cont.:tenofovir disoproxil fumarate 300mgpack: 30	$49.0K	3
Letroz 2.5 MG tabs (letrozole tablets USP 2.5MG) (act. qty. 5486 Pack x 05x05	$46.7K	1
Immutil pharmaceutical products mycophenolate mofetil USP-500MG batch no.	$42.3K	1
Atstat 20MG(atorvastatin tablets 20 MG)b/n:ap11124b & b/n:ap11224 &b/n:ap11324d/m:may-2024d/e:apr.-2027(6603x10x10t)	$28.7K	1
Tenvir (tenofovir disoproxil fumarate tablets 300MG)(1x30'sx2016 Pack=60480 nos)	$25.3K	1
Tenvir (tenofovir disoproxil fumarate tablets 300MG) (1 x 30's x 1728 Pack = 51840 nos)	$21.4K	1
Chericof throat lozenges - lemon flavourpack : box5x4s batch : eml2301 Each lozenge contains 2:4 dichlorobenzyl	$19.9K	1
Sporidex syrup 125MG.Each 5ML of the prepared suspension contains:cephalexin bpequivalent to anhydrous cephalexin	$14.9K	3
Gressami 200 pharmaceutical products amisulpride tablets BP-200MG batch no.	$9.4K	1
Warf - 1 TAB (warfarin sodium 1MG) (10 x 10's x1560 Pack=156000 nos)	$5.6K	1

JDS CO. Limited imports 23 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Leflunomide	Immunosuppressants	$600.0K	12	1.7%	2
2	Norfloxacin	Advanced Antibiotics	$115.8K	3	1.4%	10
3	Biotin	Vitamins & Supplements	$41.9K	3	2.7%	7

JDS CO. Limited imports 3 pharmaceutical products across 3 categories into Myanmar totaling $757.7K.

JDS CO. Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

JDS Co., Ltd. is a prominent pharmaceutical importer and distributor based in Myanmar, operating as a dedicated healthcare business unit of the Capital Diamond Star Group (CDSG). Established in 2003, JDS has become one of the largest healthcare groups in Myanmar, specializing in the importation, distribution, and sale of a diverse range of pharmaceutical and personal care products. The company collaborates with leading global pharmaceutical companies through various agreements, partnerships, and joint ventures to meet the growing healthcare needs of Myanmar's population. (jds.com.mm)

Headquartered in Yangon, JDS operates an extensive distribution network across Myanmar, encompassing 10 branches and 19 dealers. This widespread presence enables the company to import, distribute, and sell over 700 different pharmaceutical and personal care products to hospitals, general practitioners, retail outlets, pharmacies, wholesalers, modern trade, and government institutions. Some of the brands imported and distributed by JDS have become household names in Myanmar. (jds.com.mm)

2Distribution Network

JDS Co., Ltd. boasts an extensive distribution network throughout Myanmar, comprising 10 branches and 19 dealers. This widespread presence ensures that the company can effectively import, distribute, and sell a diverse portfolio of over 700 pharmaceutical and personal care products across the country. The company's state-of-the-art ISO-certified warehouses, including FDA-approved cold chain facilities, support the importation, storage, and distribution processes, maintaining the quality and integrity of the products. (jds.com.mm)

3Industry Role

JDS Co., Ltd. plays a pivotal role in Myanmar's pharmaceutical supply chain as a primary wholesaler and distributor. By importing and distributing a wide array of pharmaceutical and personal care products, the company ensures that hospitals, general practitioners, retail outlets, pharmacies, wholesalers, modern trade, and government institutions have access to essential medications and healthcare products. This extensive distribution network positions JDS as a key player in meeting the healthcare needs of Myanmar's population. (jds.com.mm)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — JDS CO. Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

JDS Co., Ltd. demonstrates a high degree of supplier concentration in its sourcing strategy. The company's total import value from India amounts to $758,000 USD, with 18 shipments comprising three therapeutic categories. The top five products imported are Leflunomide ($600,000, Rank #2, 1.7% share), Norfloxacin ($116,000, Rank #10, 1.4% share), and Biotin ($42,000, Rank #7, 2.7% share). The top five products account for 100% of the company's imports, indicating a complete reliance on these items. This concentration suggests a strategic choice to focus on high-demand products, but it also exposes JDS to risks associated with supply chain disruptions or changes in market demand for these specific products.

The shipment data reveals a stable relationship with Indian suppliers, with five unique suppliers identified:

CIPLA LIMITED: $252,000 (11 shipments, 44.1%)
SUN PHARMACEUTICAL INDUSTRIES LIMITED: $131,000 (8 shipments, 22.9%)
TORRENT PHARMACEUTICALS LIMITED: $100,000 (2 shipments, 17.5%)
LA RENON HEALTHCARE PRIVATE LIMITED: $59,000 (5 shipments, 10.4%)

Importing Pharmaceuticals into Myanmar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Myanmar

1Regulatory Authority & Framework

In Myanmar, the Food and Drug Administration (FDA Myanmar), under the Ministry of Health, serves as the primary regulatory authority overseeing the pharmaceutical sector. The National Drug Law, enacted in 1992, provides the legal framework governing the manufacturing, importation, exportation, storage, distribution, and sale of pharmaceutical products in the country. This legislation outlines the registration requirements for drugs, licensing procedures for pharmaceutical operations, quality assurance standards, and labeling and advertising regulations. (wipo.int)

The FDA Myanmar is responsible for ensuring that all pharmaceutical products meet safety, efficacy, and quality standards before they are permitted for importation and sale. This includes evaluating product dossiers, conducting inspections, and enforcing compliance with the National Drug Law and associated regulations. For Indian pharmaceutical exporters, understanding and adhering to these regulatory requirements is crucial for successful market entry and sustained operations in Myanmar.

2Import Licensing & GMP

Import licensing in Myanmar is governed by the Ministry of Commerce, with the Department of Trade issuing import licenses for pharmaceutical products. To obtain an import license, companies must submit an application that includes a proforma invoice, sales contract, and import price confirmation endorsed by the Myanmar Pharmaceutical & Medical Equipment Entrepreneurs' Association (MPMEEA). Additionally, the application must be accompanied by the usage of medicine, import price confirmation, and other relevant documents.

JDS CO. Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

JDS Co., Ltd.'s product strategy focuses on importing and distributing a select range of pharmaceutical products, with a significant emphasis on immunosuppressants, advanced antibiotics, and vitamins and supplements. The company's top three therapeutic categories are:

Immunosuppressants: 79.2%
Advanced Antibiotics: 15.3%

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — JDS CO. Limited

What products does JDS CO. Limited import from India?

JDS CO. Limited imports 3 pharmaceutical products across 3 categories. Top imports: Leflunomide ($600.0K), Norfloxacin ($115.8K), Biotin ($41.9K).

Who supplies pharmaceuticals to JDS CO. Limited from India?

JDS CO. Limited sources from 5 verified Indian suppliers. The primary supplier is Cipla Limited (44.1% of imports, $251.5K).

What is JDS CO. Limited's total pharmaceutical import value?

JDS CO. Limited's total pharmaceutical import value from India is $757.7K, based on 18 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does JDS CO. Limited focus on?

JDS CO. Limited imports across 3 categories. The largest: Immunosuppressants (79.2%), Advanced Antibiotics (15.3%), Vitamins & Supplements (5.5%).

Get Full JDS CO. Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 6 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

JDS CO. Limited

JDS CO. Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to JDS CO. Limited?

What Formulations Does JDS CO. Limited Import?

What Products Does JDS CO. Limited Import?

Top Products by Import Value

JDS CO. Limited Therapeutic Categories — 3 Specializations

Import Portfolio — Top 3 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Related Trade Data

Need Detailed Data?